Please login to the form below

Not currently logged in
Email:
Password:

patents

This page shows the latest patents news and features for those working in and with pharma, biotech and healthcare.

Cello Health acquires US consultancy ISS

Cello Health acquires US consultancy ISS

The technical service offering includes consultancy at all stages in the regulatory process, support of FDA advisory committee meetings, and data provision in legal defence of patent and intellectual property issues.

Latest news

More from news
Approximately 68 fully matching, plus 1,520 partially matching documents found.

Latest Intelligence

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    This includes overriding pharma patents – something the group is advocating in relation to three drugs – Vertex’s cystic fibrosis treatment Orkambi, Pfizer’s breast cancer treatment Ibrance and Roche’s breast ... Just Treatment is also urging

  • Combining therapies and combining research Combining therapies and combining research

    Wholly focused on the discovery and development of new antibiotic combinations, it has already registered 128 patents for novel combinations active against highly resistant bacteria.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Alexion is bracing for the patent expiry of its blockbuster Soliris (eculizumab), used to treat paroxysmal nocturnal haemoglobinuria (PNH) and myasthenia gravis, which hit revenues of around $3bn in 2018. ... The world’s biggest selling drug, Humira,

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    A new cliff is looming: Between 2018 and 2025, branded drugs worth more than $250bn in sales will see their patents expire.

  • Is China ready for a pharmaceutical gold rush?

    A lack of clear patent rules and regulatory transparency, as well as large-scale drug counterfeiting, gave rise to the perception that China’s market was difficult to navigate.

More from intelligence
Approximately 2 fully matching, plus 113 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Cello Health Acquire ISS

    The technical service offering includes consultancy at all stages in the regulatory process, support of FDA Advisory Committee meetings, and data provision in legal defence of patent and intellectual property

  • Making a difference with patient support

    This is just one example of how together, Bedrock and Origins deliver truly patent-centric PSPs.

  • 03 Health Services

    How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation. ... The pharma market is about to get busy. 2011–2013 marks a patent cliff, when many big-selling drugs went, or soon will go, off patent.

  • Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)

    Intellectual Property (IP). OncoSec has filed several patent applications on the various VLAs and is currently prosecuting applications related to the next-generation low-voltage generator, which provides for higher transfection

  • NHS medicines optimisation milestone

    Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry. ... prepare for the patent expiry of Adalimumab, which has the highest global turnover of any

More from PMHub
Approximately 1 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics